US FDA Advisory Committee Reboot (Part I): Open Public Meeting A Place To Start?

CDER Director Patrizia Cavazzoni raised eyebrows when she stated an intent to remove the ‘emotional overtone’ of committee meetings. The open public hearing may be a place to start.

open sign on door (Alamy)
• Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers